Taken together, theaflavins at noncytotoxic doses could protect HepG2 cells against PA-induced insulin resistance by increasing glucose uptake and modulating the IRS-1/Akt/GLUT4 pathway. This evidence concerns the gene SLC2A4 and Insulin resistance.